Logo
ScannerX
Market Intelligence
Home Fundamentals Futures Sector Trend Daily Sector Weekly Industry Daily Industry Industry Relative Strength Equity Rank Metrics Moving Average Correlation Charts Guide
Login
📰 Latest News
Oct. 19, 2026, 11:59 a.m. Akeso Announces Opening of Global Phase II Study of Ivonescimab in First-Line Clear Cell Renal Cell Carcinoma, Including Combination with Cadonilimab
Sector
Healthcare
Industry
Biotechnology
Market Cap
12.84
Volume
6,134,932
P/E
nan
ROE
-192.5
52W High
29.23
52W Low
12.07
Price Overview
Open
15.5
High
16.18
Low
15.06
Intraday Range
7.44%
20D Avg Volume
7,056,207
Distance From 52W High
-44.95%
Technical Levels
20 SMA
16.37
50 SMA
15.74
200 SMA
16.28
Last 7 Trading Days
Date Open High Low Close Volume % Change Gap % Range %
2026-10-20 15.5 16.18 15.06 16.09 6,134,932 ▲ 3.34% -0.45% 7.44%
2026-10-19 14.9 15.77 14.83 15.57 6,152,600 ▲ 6.43% 1.85% 6.34%
2026-10-16 15.39 15.41 14.56 14.63 4,331,000 ▼ -4.81% 0.13% 5.84%
2026-10-15 15.09 15.55 15.08 15.37 4,726,800 ▲ 1.59% -0.26% 3.12%
2026-10-14 15.29 15.56 15.04 15.13 4,657,100 ▼ -2.51% -1.48% 3.49%
2026-10-13 16.79 16.79 15.47 15.52 7,132,000 ▼ -9.4% -1.98% 8.57%
2026-10-12 17.48 17.59 17.05 17.13 4,371,200 ▼ nan% nan% 3.17%
Fundamentals
Business
Sector Healthcare
Industry Biotechnology
Market Cap 12.84B
Float Adj MCap 2.48B
Valuation
P/E nan
Forward P/E -13.71
P/S nan
P/B 20.26
PEG nan
Quality Metrics
ROE -192.5%
ROA -101.61%
Gross Margin 0.0%
Operating Margin 0.0%
Profit Margin 0.0%
Trading Metrics
Relative Volume 1.02
Average Volume 6.07M
Beta -1.52
Short Float 26.3%
Latest Q/Q Growth
Revenue nan%
Profit -13.87%
Operating Income -12.95%
EPS -14.63%
Quarterly History
Revenue Qtrs 0.0, 0.0, 0.0, 0.0
Profit Qtrs -0.22, -0.19, -0.22, -0.23
Operating Qtrs -0.22, -0.2, -0.22, -0.23
EPS Qtrs -0.28, -0.24, -0.29, -0.31